Rubicon Founders LLC Purchases Shares of 105,341 Agilon Health, Inc. $AGL

Rubicon Founders LLC purchased a new stake in Agilon Health, Inc. (NYSE:AGL) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 105,341 shares of the company’s stock, valued at approximately $11,290,448,000. Agilon Health comprises 5.7% of Rubicon Founders LLC’s investment portfolio, making the stock its 3rd biggest position. Rubicon Founders LLC owned approximately 0.63% of Agilon Health at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. LPL Financial LLC raised its position in shares of Agilon Health by 213.4% during the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock worth $30,000 after purchasing an additional 30,000 shares during the last quarter. CIBC Bancorp USA Inc. purchased a new position in Agilon Health during the third quarter worth $34,000. Merit Financial Group LLC acquired a new position in shares of Agilon Health in the fourth quarter worth $35,000. Focus Partners Advisor Solutions LLC acquired a new position in shares of Agilon Health in the fourth quarter worth $53,000. Finally, Alpine Global Management LLC purchased a new stake in shares of Agilon Health in the fourth quarter valued at $84,000.

Agilon Health Price Performance

AGL stock opened at $93.74 on Tuesday. Agilon Health, Inc. has a 52-week low of $7.48 and a 52-week high of $133.04. The stock’s fifty day simple moving average is $105.44 and its 200-day simple moving average is $61.69. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $1.57 billion, a price-to-earnings ratio of -6.57 and a beta of 3.01.

Agilon Health (NYSE:AGL) last released its earnings results on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, beating the consensus estimate of $0.14 by $0.90. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%.The firm had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.45 billion. Equities research analysts expect that Agilon Health, Inc. will post -2.95 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts recently commented on AGL shares. JPMorgan Chase & Co. increased their price objective on Agilon Health from $31.00 to $85.00 and gave the company an “underweight” rating in a research note on Monday. Deutsche Bank Aktiengesellschaft raised shares of Agilon Health from a “hold” rating to a “buy” rating and raised their price target for the stock from $33.00 to $49.00 in a research note on Thursday, May 7th. Jefferies Financial Group upgraded shares of Agilon Health from a “hold” rating to a “buy” rating and lifted their price target for the stock from $27.50 to $48.00 in a report on Thursday, May 7th. Barclays set a $111.00 price target on shares of Agilon Health and gave the stock an “equal weight” rating in a report on Thursday, August 6th. Finally, Citigroup raised shares of Agilon Health from a “sell” rating to a “neutral” rating and upped their price objective for the company from $105.00 to $115.00 in a research note on Monday, August 10th. Five equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $97.70.

Agilon Health Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.